サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542785

クレアチニン測定キットの世界市場

Creatinine Assay Kits

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
クレアチニン測定キットの世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

クレアチニン測定キットの世界市場は2030年までに2億2,720万米ドルに達する見込み

2023年に1億9,500万米ドルと推定されるクレアチニン測定キットの世界市場は、2030年には2億2,720万米ドルに達し、分析期間2023-2030年のCAGRは2.2%で成長すると予測されます。本レポートで分析したセグメントの1つであるヤッホーキネティックテストキットは、CAGR 2.1％を記録し、分析期間終了までに1億210万米ドルに達すると予測されます。クレアチニン-PAP検査キット分野の成長率は、分析期間中CAGR 2.8％と推定されます。

米国市場は5,150万米ドルと推定、中国はCAGR 2.1％で成長予測

米国のクレアチニン測定キット市場は2023年に5,150万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3,660万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは2.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と1.8％と予測されています。欧州では、ドイツがCAGR 2.4%で成長すると予測されています。

世界のクレアチニン測定キット市場- 主要動向と促進要因まとめ

腎臓チェック医療診断においてクレアチニン測定キットが重要な理由とは？

クレアチニン測定キットは、血液や尿サンプル中のクレアチニンレベルを迅速かつ正確に測定する、臨床現場には欠かせないツールです。クレアチニンは、筋肉の代謝から発生する老廃物で、腎機能の重要な指標です。これらのキットは、クレアチニン濃度を評価するために、ヤッフェの速度論的方法や酵素アッセイを含む様々な手法を利用します。この結果は、ヘルスケアプロバイダーが腎疾患の診断とモニタリングにおいて重要なパラメータである糸球体濾過量（GFR）を評価するのに役立ちます。腎機能が低下するとクレアチニン濃度が上昇し、腎障害や腎不全の可能性を示唆します。このように、クレアチニン測定は腎臓病の早期発見と継続的管理において極めて重要な役割を果たし、タイムリーな介入と治療のカスタマイズを保証します。

クレアチニン測定技術の進歩は患者ケアをどのように向上させたか？

クレアチニン検査の分野では、これらの検査の精度、効率、利便性を向上させる重要な技術的進歩が見られました。最新のクレアチニン測定キットは自動分析装置と高い互換性を持つように設計されており、ルーチンの検査室ワークフローにシームレスに統合することができます。これらの進歩には、サンプル中の他の物質からの干渉を低減し、より信頼性の高い結果を保証する試薬処方の改良が含まれます。さらに、POC（ポイント・オブ・ケア）クレアチニン検査装置の開発は、即座の臨床判断をサポートする迅速な結果を提供することで、特にクリティカルケアや緊急時の患者管理に革命をもたらしました。このような技術革新は、患者ケアを最適化するだけでなく、従来の検査法に比べて所要時間を大幅に短縮します。

クレアチニン測定キットの使用に影響する課題とは？

その利点にもかかわらず、クレアチニン測定キットの展開はいくつかの課題に直面しています。大きな問題の一つは、メーカーごとの検査デザインや感度の違いによるアッセイ結果のばらつきです。これはクレアチニンの測定値に一貫性がないことにつながり、腎臓の健康管理に関する臨床判断に影響を与える可能性があります。さらに、患者の検体中に特定の化学物質や薬剤が存在すると、クレアチニン測定値の精度が阻害され、値が誤って高くなったり低くなったりすることがあります。このような課題に対処するには、多様な臨床環境や集団においてクレアチニン測定の信頼性と有効性を確保するための継続的な調査と標準化の取り組みが必要です。

クレアチニン測定キット市場を促進する主な要因は？

クレアチニン測定キット市場の成長は、予防ヘルスケアと慢性疾患管理への関心の高まりを反映するいくつかの要因によって牽引されています。慢性腎臓病（CKD）の危険因子として知られる高血圧や糖尿病などの疾患の有病率が上昇しているため、日常的な健康診断でクレアチニン測定がより多く使用されるようになっています。特に新興諸国におけるヘルスケア・インフラの開拓は、こうした診断検査へのアクセスを拡大し、市場の成長をさらに後押ししています。さらに、腎機能が低下しやすい世界の高齢化により、定期的な腎機能モニタリングの必要性が強調されています。これらのキットの精度と使いやすさを向上させる技術の進歩も、キットの採用拡大に寄与しています。患者の予後を改善し医療費を削減するために、世界中の医療機関が腎臓病の早期発見と管理を重視しているため、クレアチニン測定キットの需要は今後も高まり続けると予想されます。

調査対象企業の例（全46件）

  • Abbott Laboratories
  • Abcam PLC
  • Arbor Assays Inc.
  • BioAssay Systems
  • Biovision Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Crystal Chem, Inc.
  • Enzo Life Sciences, Inc.
  • Genway Biotech, Inc.
  • Merck KgaA
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Tulip Diagnostics（P）Ltd.
  • Wako Pure Chemical Industries Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11363

Global Creatinine Assay Kits Market to Reach US$227.2 Million by 2030

The global market for Creatinine Assay Kits estimated at US$195.0 Million in the year 2023, is expected to reach US$227.2 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Jaffe's Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the end of the analysis period. Growth in the Creatinine-PAP Test Kits segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$51.5 Million While China is Forecast to Grow at 2.1% CAGR

The Creatinine Assay Kits market in the U.S. is estimated at US$51.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.6 Million by the year 2030 trailing a CAGR of 2.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Creatinine Assay Kits Market - Key Trends and Drivers Summarized

Kidney Check: Why Are Creatinine Assay Kits Crucial in Medical Diagnostics?

Creatinine assay kits are essential tools in clinical settings, providing quick and accurate measurements of creatinine levels in blood and urine samples. Creatinine, a waste product generated from muscle metabolism, is a key indicator of kidney function. These kits utilize various methodologies, including Jaffe's kinetic method and enzymatic assays, to evaluate creatinine concentration. The results help healthcare providers assess the glomerular filtration rate (GFR), a critical parameter in diagnosing and monitoring kidney diseases. As kidney function declines, creatinine levels rise, signaling potential renal impairment or failure. Thus, creatinine assays play a pivotal role in early detection and ongoing management of kidney diseases, ensuring timely intervention and treatment customization.

How Have Advancements in Creatinine Assay Technology Enhanced Patient Care?

The field of creatinine testing has seen significant technological advancements that have enhanced the accuracy, efficiency, and convenience of these tests. Modern creatinine assay kits are designed for high compatibility with automated analyzers, allowing for seamless integration into routine laboratory workflows. These advancements include improved reagent formulations that reduce interference from other substances in the sample, ensuring more reliable results. Additionally, the development of point-of-care creatinine testing devices has revolutionized patient management, especially in critical care and emergency settings, by providing rapid results that support immediate clinical decisions. Such innovations not only optimize patient care but also significantly decrease the turnaround time compared to traditional laboratory methods.

What Challenges Influence the Use of Creatinine Assay Kits?

Despite their benefits, the deployment of creatinine assay kits faces several challenges. One major issue is the variability in assay results due to differences in test design and sensitivity among different manufacturers. This can lead to inconsistencies in creatinine measurements, affecting clinical decisions related to kidney health management. Furthermore, the presence of certain chemicals or drugs in patients' samples can interfere with the accuracy of creatinine assays, leading to either falsely elevated or reduced levels. Addressing these challenges requires ongoing research and standardization efforts to ensure that creatinine assays remain reliable and effective across diverse clinical environments and populations.

What Are the Major Drivers Propelling the Creatinine Assay Kits Market Forward?

The growth in the creatinine assay kits market is driven by several factors, reflecting an increased focus on preventive healthcare and chronic disease management. The rising prevalence of conditions such as hypertension and diabetes, which are known risk factors for chronic kidney disease (CKD), has led to greater use of creatinine assays in routine health screenings. Advances in healthcare infrastructure, particularly in developing countries, have expanded access to these diagnostic tests, further propelling market growth. Additionally, the aging global population, which is more susceptible to renal function decline, underscores the need for regular kidney function monitoring. Technological advancements that improve the accuracy and user-friendliness of these kits also contribute to their increased adoption. As health systems worldwide emphasize early detection and management of kidney disease to improve patient outcomes and reduce healthcare costs, the demand for creatinine assay kits is expected to continue rising.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • Arbor Assays Inc.
  • BioAssay Systems
  • Biovision Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Crystal Chem, Inc.
  • Enzo Life Sciences, Inc.
  • Genway Biotech, Inc.
  • Merck KgaA
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Tulip Diagnostics (P) Ltd.
  • Wako Pure Chemical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Creatinine Assay Kits - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Kidney Disease Propels Demand for Creatinine Assay Kits
    • Global Aging Population Drives Adoption of Kidney Function Tests
    • Growing Health Awareness and Preventative Care Boost Use of Creatinine Assays
    • Healthcare Infrastructure Expansion in Developing Countries Spurs Market Demand
    • Standardization of Renal Function Testing Protocols Bolsters Reliability and Adoption
    • Rise in Diabetes Incidence Intensifies Need for Routine Kidney Function Monitoring
    • Insurance Coverage for Routine Health Screening Supports Market Penetration
    • Impact of Telehealth on Remote Patient Monitoring Boosts Creatinine Assay Use
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Creatinine Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Creatinine Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Creatinine-PAP Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Creatinine-PAP Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Creatinine-PAP Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for ELISA Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for ELISA Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for ELISA Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Creatinine Assay Kits Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jaffe's Kinetic Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jaffe's Kinetic Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jaffe's Kinetic Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Blood / Serum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Blood / Serum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Blood / Serum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • JAPAN
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • CHINA
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • EUROPE
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Creatinine Assay Kits by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Creatinine Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • FRANCE
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • GERMANY
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030

IV. COMPETITION